Navigation Links
Creating an 'electronic nose' to sniff out tuberculosis from a patient's breath
Date:11/7/2011

A new hand-held device called the Electronic Nose, which has the potential to diagnose tuberculosis (TB) in symptomatic patients, was awarded a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation today to support further development and testing of this ground-breaking technology.

The funding will help determine whether the Electronic Nose is able to detect TB immediately and non-invasively from the patient's breath, in order to replace time-consuming testing with sputum.

It is estimated that up to 400,000 lives a year can be saved in the developing world by early diagnosis, immediate treatment and reduced transmission of this killer disease.

TB has been all but eliminated in the developing world, but in poor countries it claims close to 1.7 million lives yearly and is second only to HIV/AIDs as the world's most deadly infectious disease.

"This important discovery is testimony to the power of innovation to save lives," said Dr. Peter Singer, CEO of Grand Challenges Canada. "Diagnosing TB and other pulmonary disease simply by testing a patient's breath is a bold idea with potentially big impact."

The development of the Electronic Nose is a collaboration between the International Centre for Genetic Engineering and Biotechnology in New Delhi, India, and Next Dimension Technologies in California. The New Delhi innovators are working with sensors developed in California to track biomarkers in the breath. Those biomarkers may hold promise to identify TB disease, leading to earlier diagnosis and improved patient treatment.

"We hope to take the concept of the Electronic Nose to the next level by developing and testing a prototype of the hand-held, battery-powered device," said Prof. Virander Chauhan and Dr. Ranjan Nanda, lead researchers. "Our goal is to make the Electronic Nose widely available in poor, remote areas where tuberculosis often breeds and spreads, devastating so many lives."

Scientists say Electronic Noses could also be created for early detection of lung cancer and pneumonia, based on signature biomarkers of that disease detectable in a patient's breath.

"Grand Challenges Explorations aims to tackle critical health and development challenges by funding creative, high-risk concepts that show the greatest potential for impact," said Chris Wilson, Director of Global Health Discovery at the Bill & Melinda Gates Foundation. "With this additional phase of funding, we're excited to move the most promising projects closer to products that could ultimately save millions of lives."

"Imagine detecting tuberculosis through a person's breath and the number of people who can be saved," said Joseph L. Rotman, Chair of Grand Challenges Canada. "We are pleased to support this discovery and, through Grand Challenges Canada's Integrated Innovation approach, to ensure rapid patient utilization and commercialization, so that the Electronic Nose is available, cost-effectively."


'/>"/>
Contact: Terry Collins
tc@tca.tc
416-538-8712
McLaughlin-Rotman Centre for Global Health
Source:Eurekalert  

Related biology news :

1. Better beer: College team creating anticancer brew
2. Argonne scientists discover possible mechanism for creating handedness in biological molecules
3. Creating ideal neural cells for clinical use
4. Marine microbes creating green waves in industry
5. Marine microbes creating green waves in industry
6. Stimulus-funded university research addressing issues from climate change to cancer, creating jobs and training a new generation of scientists
7. Melting tundra creating vast river of waste into Arctic Ocean
8. Scientists are first to unlock the mystery of creating cultured pearls from the queen conch
9. Forest deal at Copenhagen must avoid creating carbon refugees
10. VAI researchers find long awaited key to creating drought resistant crops
11. Creating a dream breed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Creating an 'electronic nose' to sniff out tuberculosis from a patient's breath
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited ... to the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... the largest German biometrics company the two government leaders could see the ... well as DERMALOGĀ“s multi-biometrics system.   Continue Reading ... ...
(Date:3/13/2017)... HAMBURG, Germany , March 13, 2017 Future of ... ... DERMALOGs Face Matching enables to match ... characteristics forms the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for ...
(Date:3/7/2017)... -- Brandwatch , the leading social intelligence company, today announces ... to uncover insights to support its reporting, help direct future campaigns, ... leading youth charity will be using Brandwatch Analytics social listening and ... understanding of the topics and issues that are a priority for ... "Until ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... DUBLIN , March 27, 2017 ... access to a comprehensive library of reports on Valero ... the transportation fuels and petrochemical industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... is biofuel production to go green. Ethanol today, even though ...
(Date:3/27/2017)... , March 27, 2017  Trovagene, Inc. (NASDAQ: TROV), ... Chief Executive Officer, Bill Welch , will be ... 2017 at 9:00 AM EDT at the Essex House ... Welch, and Chief Scientific Officer, Mark Erlander , ... during the conference.   The presentation will be ...
(Date:3/24/2017)... , March 24, 2017 MiMedx Group, Inc. ... utilizing human placental tissue allografts and patent-protected processes to ... sectors of healthcare, announced today  that it will present ... York , NY.  Parker H. "Pete" Petit, Chairman ... Officer, Christopher M. Cashman , EVP and Chief ...
(Date:3/24/2017)... Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of ... its board of directors has amended its shareholder rights plan. The amendment ... to March 27, 2018. The amendment was not in response to any ... ... is a China -based biopharmaceutical company that focuses ...
Breaking Biology Technology: